They will restart after weight regain
Is it better to inject tirzepatide on an empty or full stomach
Because these receptors exist in different parts of the body, like the brain, there may be some options or possibilities in the future to use them for other types of conditions, Laura Anglim, OTP Prescriber for the Zepf Center said
A multicenter, phase 3 RDBPCT study to evaluate the efficacy and safety of elafibranor in NASH without cirrhosis is ongoing (RESOLVE-IT) (NCT02704403)
References: GLP-1 Single, Dual, and Triple Receptor Agonists The Lancet eClinicalMedicine 2024 GLP-1 Receptor Agonists State of the Art PMC Emerging Frontiers in GLP-1 Therapeutics 2025 PMC SGLT2 Inhibitors Jardiance & Farxiga: The Diabetes Drug That Protects Your Heart and Kidneys Here is something remarkable
Approval may take time and is not guaranteed